The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer

BACKGROUND: Amplification of the human epidermal growth factor receptor 2 (HER2) gene occurs in approximately 20% of invasive breast cancer cases and is associated with a more aggressive disease course than HER2-negative breast cancer. HER2-targeted therapies have altered the natural history of HER2...

Descripción completa

Detalles Bibliográficos
Autores principales: Tripathy, Debu, Rugo, Hope S, Kaufman, Peter A, Swain, Sandra, O’Shaughnessy, Joyce, Jahanzeb, Mohammad, Mason, Ginny, Beattie, Mary, Yoo, Bongin, Lai, Catherine, Masaquel, Anthony, Hurvitz, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011780/
https://www.ncbi.nlm.nih.gov/pubmed/24885258
http://dx.doi.org/10.1186/1471-2407-14-307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011780/
https://www.ncbi.nlm.nih.gov/pubmed/24885258
http://dx.doi.org/10.1186/1471-2407-14-307

Ejemplares similares